Table 5.
Study | Type of study and surgery | Number of patients | Cardiac biomarker (time) | Other features | Major findings |
---|---|---|---|---|---|
Greenson et al.43 | Single centre prospective study; CABG or Aortic valve replacement | 100 |
|
Pre-op, 24 h and 48 h, then daily until discharge or 1 week | Peak cTnI > 60 ng/mL (> 120× URL) predictive of cardiac events up to 30 days post op |
Holmvang et al.35 | Single centre prospective study, CABG only | 103 |
|
Every 2 h in first 20 h, 24, 30, 36 and 48 h, 72 and 98 h |
|
Eigel et al.44 | Prospective single centre study; CABG only (Excluded MI within 7 days) | 540 | cTnI | Prior to induction of anaesthesia and at termination of CPB | cTnI level > 0.495 ng/L (> 9.9× URL for assay) measured at the end of CPB was predictive of in-hospital adverse outcomes (MI/death) |
Lasocki et al.45 | Single centre prospective study; CABG or valve surgery (Acute MI < 7 days were excluded) | 502 |
|
20 h post-op |
|
Thielmann et al.46 | Single centre prospective study: CABG only | 2,078 | cTnI | 1, 6, 12,24 h post op |
|
Paparella et al.47 | Prospective Single centre study; CABG only (Patients with UA/MI < 7 days included) | 230 | cTnI | Pre-op, 1,6,12,24 and 36 h post-op, daily from day 2 to 7 |
|
Onorati et al.9 | Prospective single centre study; CABG only | 776 |
|
Pre-op and 12, 24, 48 and 72 h post-op | cTnI >3.1 μg/L (> 310× URL) at 12 h predicted increased in-hospital and 12 month mortality; Additional ECG and ECHO criteria of MI predicted worst outcome |
Thielmann et al.31,48 |
|
94 |
|
Pre-op, 1, 6, 12, 24, 36 and 48 h post-op | cTnI was the best discriminator between PMI ′in general′ and ′inherent′ release of cTnI after CABG with a cut-off value of 10.5 ng/mL (> 21× URL) and between graft-related and non-graft-related PMI with a cut-off value of 35.5 ng/mL (>71× URL). CK-MB level and ECG changes/TEE could not differentiate between those with or without graft failure. |
Croal et al.49 |
|
1365 |
|
2 and 24 h |
|
Provenchère et al.50 |
|
92 | cTnI | 20 h post op | cTnI levels were not predictive of 1 year mortality in a multivariate model. |
Fellahi et al.51 |
|
202 | cTnI | Per-op and 24 h post-op |
|
Adabag et al.34 |
|
1186 |
|
Ever 8 h for 24 h post-op, longer if no peak in 24 h | cTnI level independently associated with operative (30 day) mortality; CK-MB had a weaker association with operative mortality |
Muehlschlegel et al.26 |
|
1013 | cTnI | Daily from day 1 to 5 |
|
Petaja et al.41 |
|
2348–3271 | cTnI | Up to 7 days post op |
|
Hashemzadeh et al.52 |
|
320 | cTnI | Immediately and 20 h post-op | 20 h post-op cTnI had better prognostic value than immediate post-op levels. 20 h cTnI level was an independent predictor of in-hospital mortality above a value of 14 ng/mL (>10× URL) |
Van Geene et al.53 | Registry retrospective analysis;CABG and/or valve surgery | 938 (Separate validation subset, n = 579) | cTnI | 1 h post-op | 1 h post-op cTn values correlated with hospital mortality with the best cut-off value of 4.25 μ/L (Type of assay and URL for assay not known) |
Domanski et al.29 |
|
18,908 | cTnI | <24 h post op |
|
Ranasinghe et al.27 | Retrospective analysis of 2 prospective randomized controlled clinical trials | 440 | cTnI | 6, 12, 24, 48, 72 h post-op |
|
AUC, area under the curve; CABG, coronary artery bypass grafting; CMR, cardiac MRI; CK-MB, creatine kinase-MB fraction; d, day; ECG, electrocardiogram; ECHO, echocardiocardiogram; HR, hazards ratio; h, hour; LGE, late gadolinium enhancement; LV, left ventricle; MACE, major adverse cardiac events; MI, myocardial infarction; mth, month; ng, nanogram; ONBEAT, on-pump beating heart; CABG ONSTOP, on-pump CABG; OR, odds ratio; post-op, post-operative; PMI, perioperative myocardial injury; RR, relative risk; TEE, transoesophageal echocardiogram; cTnI, Troponin I; cTnT, Troponin T; UA, unstable angina; URL, upper reference limit; yr, year.